StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cellectar Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$23.53M. For fiscal 2025 it was -$22.98M. The highest annual figure on record is -$4.19M in fiscal 2010.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.98M–
FY2024Dec 31, 2024-$51.78M–
FY2023Dec 31, 2023-$38.96M–
FY2022Dec 31, 2022-$28.81M–
FY2021Dec 31, 2021-$24.13M–
FY2020Dec 31, 2020-$15.29M–
FY2019Dec 31, 2019-$14.18M–
FY2018Dec 31, 2018-$13.33M–
FY2017Dec 31, 2017-$13.60M–
FY2016Dec 31, 2016-$9.45M–
FY2015Dec 31, 2015-$8.76M–
FY2014Dec 31, 2014-$9.89M–
FY2013Dec 31, 2013-$12.40M–
FY2012Dec 31, 2012-$8.75M–
FY2011Dec 31, 2011-$7.04M–
FY2010Dec 31, 2010-$4.19M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.20M–
Q1 FY2026Mar 31, 2026-$5.79M–
Q4 FY2025Dec 31, 2025-$5.69M–
Q3 FY2025Sep 30, 2025-$4.85M–
Q2 FY2025Jun 30, 2025-$6.04M–
Q1 FY2025Mar 31, 2025-$6.40M–
Q4 FY2024Dec 31, 2024-$12.74M–
Q3 FY2024Sep 30, 2024-$13.33M–
Q2 FY2024Jun 30, 2024-$13.70M–
Q1 FY2024Mar 31, 2024-$12.00M–
Q4 FY2023Dec 31, 2023-$12.55M–
Q3 FY2023Sep 30, 2023-$9.41M–
Q2 FY2023Jun 30, 2023-$8.29M–
Q1 FY2023Mar 31, 2023-$8.71M–
Q4 FY2022Dec 31, 2022-$7.42M–
Q3 FY2022Sep 30, 2022-$7.82M–
Q2 FY2022Jun 30, 2022-$7.44M–
Q1 FY2022Mar 31, 2022-$6.14M–
Q4 FY2021Dec 31, 2021-$5.92M–
Q3 FY2021Sep 30, 2021-$5.82M–
Q2 FY2021Jun 30, 2021-$6.03M–
Q1 FY2021Mar 31, 2021-$6.36M–
Q4 FY2020Dec 31, 2020-$3.80M–
Q3 FY2020Sep 30, 2020-$3.91M–
Q2 FY2020Jun 30, 2020-$3.62M–
Q1 FY2020Mar 31, 2020-$3.96M–
Q4 FY2019Dec 31, 2019-$3.38M–
Q3 FY2019Sep 30, 2019-$3.96M–
Q2 FY2019Jun 30, 2019-$3.20M–
Q1 FY2019Mar 31, 2019-$3.63M–
Q4 FY2018Dec 31, 2018-$3.88M–
Q3 FY2018Sep 30, 2018-$3.09M–
Q2 FY2018Jun 30, 2018-$2.90M–
Q1 FY2018Mar 31, 2018-$3.45M–
Q4 FY2017Dec 31, 2017-$4.09M–
Q3 FY2017Sep 30, 2017-$3.48M–
Q2 FY2017Jun 30, 2017-$3.22M–
Q1 FY2017Mar 31, 2017-$2.81M–
Q4 FY2016Dec 31, 2016-$2.65M–
Q3 FY2016Sep 30, 2016-$2.47M–

More Cellectar Biosciences figures

See a number that looks wrong?